RESUMO
Malodorants are mixtures containing mercaptans, which trigger the flight instinct upon exposure and might thus be deployed in military and civilian defense scenarios. Exposure to mercaptans might lead to unconsciousness, thus representing a possible threat for health. Therefore, we developed and validated a bioanalytical procedure for the simultaneous detection and identification of corresponding biomarkers for the verification of exposure to mercaptans. Disulfide-adducts of ethyl mercaptan (SEt), n-butyl mercaptan (SnBu), tert-butyl mercaptan (StBu) and iso-amyl mercaptan (SiAm) with cysteine (Cys) residues in human serum albumin (HSA) were formed by in vitro incubation of human plasma. After pronase-catalyzed proteolysis, reaction products were identified as adducts of the single amino acid Cys and the dipeptide cysteine-proline (Cys34Pro) detected by a sensitive µLC-ESI MS/MS method working in the scheduled multiple reaction monitoring (sMRM) mode. Dose-response studies showed linearity for the yield of Cys34Pro-adducts in the range from 6 nM to 300 µM of mercaptans in plasma and limits of identification (LOI) were in the range from 60 nM to 6 µM. Cys34-adducts showed stability for at least 6 days in plasma (37 °C). The presented disulfide-biomarkers expand the spectrum for bioanalytical verification procedures and might be helpful to prove exposure to malodorants.
Assuntos
Cisteína , Dissulfetos , Albumina Sérica Humana , Compostos de Sulfidrila , Humanos , Cisteína/química , Cisteína/sangue , Albumina Sérica Humana/química , Dissulfetos/química , Compostos de Sulfidrila/química , Espectrometria de Massas em Tandem/métodos , Odorantes/análise , Biomarcadores/sangueRESUMO
RATIONALE: A common strategy for antibody-drug conjugate (ADC) quantitation from in vivo study samples involves measurement of total antibody, conjugated ADC, and free payload concentrations using multiple reaction monitoring (MRM) mass spectrometry. This not only provides a limited picture of biotransformation but can also involve lengthy method development. Quantitation of ADCs directly at the intact protein level in native conditions using high-resolution mass spectrometers presents the advantage of measuring exposure readout as well as monitoring the change in average drug-to-antibody ratio (DAR) and in vivo stability of new linker payloads with minimal method development. Furthermore, site-specific cysteine-conjugated ADCs often rely on non-covalent association to retain their quaternary structure, which highlights the unique capabilities of native mass spectrometry (nMS) for intact ADC quantitation. METHODS: We developed an intact quantitation workflow involving three stages: automated affinity purification, nMS analysis, and data processing in batch fashion. The sample preparation method was modified to include only volatile ion-pairing reagents in the buffer systems. A capillary size-exclusion chromatography (SEC) column was coupled to a quadrupole time-of-flight high-resolution mass spectrometer for high-throughput nMS analysis. Samples from two mouse pharmacokinetic (PK) studies were analyzed using both intact quantitation workflow and the conventional MRM-based approach. RESULTS: A linear dynamic range of 5-100 µg/mL was achieved using 20 µL of serum sample volume. The results of mouse in vivo PK measurement using the intact quantitation workflow and the MRM-based approach were compared, revealing excellent method agreement. CONCLUSIONS: We demonstrated the feasibility of utilizing nMS for the quantitation of ADCs at the intact protein level in preclinical PK studies. Our results indicate that this intact quantitation workflow can serve as an alternative generic method for high-throughput analysis, enabling an in-depth understanding of ADC stability and safety in vivo.
Assuntos
Cisteína , Imunoconjugados , Espectrometria de Massas , Imunoconjugados/química , Imunoconjugados/farmacocinética , Imunoconjugados/sangue , Imunoconjugados/análise , Cisteína/química , Cisteína/sangue , Animais , Camundongos , Espectrometria de Massas/métodos , Cromatografia em Gel/métodosRESUMO
BACKGROUND: Acute ischemic stroke (AIS) is one of the most common cerebrovascular diseases which accompanied by a disruption of aminothiols homeostasis. To explore the relationship of aminothiols with neurologic impairment severity, we investigated four aminothiols, homocysteine (Hcy), cysteine (Cys), cysteinylglycine (CG) and glutathione (GSH) in plasma and its influence on ischemic stroke severity in AIS patients. METHODS: A total of 150 clinical samples from AIS patients were selected for our study. The concentrations of free reduced Hcy (Hcy), own oxidized Hcy (HHcy), free reduced Cys (Cys), own oxidized Cys (cysteine, Cyss), free reduced CG (CG) and free reduced GSH (GSH) were measured by our previously developed hollow fiber centrifugal ultrafiltration (HFCF-UF) method coupled with high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The concentration ratio of Hcy to HHcy (Hcy/HHcy), Cys to Cyss (Cys/Cyss) were also calculated. The neurologic impairment severity of AIS was evaluated using National Institutes of Health Stroke Scale (NIHSS). The Spearman correlation coefficient and logistic regression analysis was used to estimate and perform the correlation between Hcy, HHcy, Cys, Cyss, CG, GSH, Hcy/HHcy, Cys/Cyss and total Hcy with NIHSS score. RESULTS: The reduced Hcy and Hcy/HHcy was both negatively correlated with NIHSS score in AIS patients with P = 0.008, r=-0.215 and P = 0.002, r=-0.249, respectively. There was no significant correlation of Cys, CG, GSH, HHcy, Cyss, Cys/Cyss and total Hcy with NIHSS score in AIS patients with P value > 0.05. CONCLUSIONS: The reduced Hcy and Hcy/HHcy, not total Hcy concentration should be used to evaluate neurologic impairment severity of AIS patient.
Assuntos
Cisteína , Glutationa , Homocisteína , AVC Isquêmico , Oxirredução , Índice de Gravidade de Doença , Humanos , Masculino , Feminino , AVC Isquêmico/sangue , AVC Isquêmico/diagnóstico , Homocisteína/sangue , Idoso , Pessoa de Meia-Idade , Cisteína/sangue , Glutationa/sangue , Dipeptídeos/sangue , Idoso de 80 Anos ou maisRESUMO
Copper-cobalt bimetallic nitrogen-doped carbon-based nanoenzymatic materials (CuCo@NC) were synthesized using a one-step pyrolysis process. A three-channel colorimetric sensor array was constructed for the detection of seven antioxidants, including cysteine (Cys), uric acid (UA), tea polyphenols (TP), lysine (Lys), ascorbic acid (AA), glutathione (GSH), and dopamine (DA). CuCo@NC with peroxidase activity was used to catalyze the oxidation of TMB by H2O2 at three different ratios of metal sites. The ability of various antioxidants to reduce the oxidation products of TMB (ox TMB) varied, leading to distinct absorbance changes. Linear discriminant analysis (LDA) results showed that the sensor array was capable of detecting seven antioxidants in buffer and serum samples. It could successfully discriminate antioxidants with a minimum concentration of 10 nM. Thus, multifunctional sensor arrays based on CuCo@NC bimetallic nanoenzymes not only offer a promising strategy for identifying various antioxidants but also expand their applications in medical diagnostics and environmental analysis of food.
Assuntos
Antioxidantes , Carbono , Colorimetria , Cobre , Nitrogênio , Nitrogênio/química , Colorimetria/métodos , Carbono/química , Antioxidantes/química , Antioxidantes/análise , Cobre/química , Cobalto/química , Peróxido de Hidrogênio/química , Humanos , Catálise , Limite de Detecção , Glutationa/química , Glutationa/sangue , Dopamina/sangue , Dopamina/análise , Dopamina/química , Benzidinas/química , Polifenóis/química , Polifenóis/análise , Ácido Ascórbico/química , Ácido Ascórbico/sangue , Ácido Ascórbico/análise , Oxirredução , Ácido Úrico/sangue , Ácido Úrico/química , Ácido Úrico/análise , Cisteína/química , Cisteína/sangueRESUMO
Cysteine (Cys) is one of the most basic mercaptans in the human body. As an important endogenous small molecule mercaptan, Cys plays a vital role in various physiological processes and can participate in maintaining redox balance to ensure homeostasis. Abnormal Cys levels can lead to a variety of diseases. However, the detection of cysteine may be interfered with by other small molecule biothiols. Therefore, the design of fluorescent probes based on the structural characteristics and reactivity of cysteine has become the focus of current research. In this paper, a fluorescent probe (3-(2H-benzo[d][1,2,3]triazol-2-yl)-2-oxo-2H-benzo[g]chromen-8-yl acrylate, BTAB) for Cys detection was synthesized with acrylic ester as the reaction site. Under the conditions of gradual optimization, BTAB can achieve selectivity and anti-interference ability for Cys detection. The linear range of Cys was 0.3-10 µM, and the detection limit was 0.154 µM. Finally, this probe was applied to detect the Cys content in bovine serum samples with satisfactory results.
Assuntos
Cisteína , Corantes Fluorescentes , Limite de Detecção , Espectrometria de Fluorescência , Cisteína/sangue , Cisteína/química , Corantes Fluorescentes/química , Bovinos , Animais , Espectrometria de Fluorescência/métodosRESUMO
We present a colorimetric probe based on polyvinylpyrrolidone-capped gold nanoparticles (PVP-AuNPs) that is sensitive and selective for cysteine (Cys). A microfluidic paper-based analytical device (µ-PAD) with embedded dried PVP-AuNPs at the polyethersulfone (PES) paper surface is used for Cys detection. When thiol molecules attach to PVP-AuNPs in the presence of Cys, they clump together, and this causes the solution's color to shift from red to blue within 5 minutes. The device is capable of detecting Cys levels between 1.0 µM and 50.0 µM with a limit of detection (LOD) of 0.2 µM under optimized conditions. The stability of the µ-PAD was tested for 100 days, demonstrating re-dispersibility to detect Cys levels in blood. Dried PVP-AuNP-µPADs were integrated with blood plasma separation modules for point-of-care (POC) Cys detection. Consequently, the device shows potential as a self-sustaining, quantification platform with a recovery percentage ranging from 98.44 to 111.9 in clinical samples.
Assuntos
Colorimetria , Cisteína , Ouro , Limite de Detecção , Nanopartículas Metálicas , Papel , Sistemas Automatizados de Assistência Junto ao Leito , Ouro/química , Cisteína/sangue , Cisteína/química , Nanopartículas Metálicas/química , Humanos , Colorimetria/métodos , Colorimetria/instrumentação , Povidona/química , Técnicas Analíticas Microfluídicas/instrumentação , Técnicas Analíticas Microfluídicas/métodosRESUMO
One-carbon metabolism (OCM) is a complex and interconnected network that undergoes drastic changes during pregnancy. In this study, we investigated the longitudinal distribution of OCM-related metabolites in maternal and cord blood and explored their relationships. Additionally, we conducted cross-sectional analyses to examine the interrelationships among these metabolites. This study included 146 healthy pregnant women who participated in the Chiba Study of Mother and Child Health. Maternal blood samples were collected during early pregnancy, late pregnancy, and delivery, along with cord blood samples. We analyzed 18 OCM-related metabolites in serum using stable isotope dilution liquid chromatography/tandem mass spectrometry. We found that serum S-adenosylmethionine (SAM) concentrations in maternal blood remained stable throughout pregnancy. Conversely, S-adenosylhomocysteine (SAH) concentrations increased, and the total homocysteine/total cysteine ratio significantly increased with advancing gestational age. The betaine/dimethylglycine ratio was negatively correlated with total homocysteine in maternal blood for all sampling periods, and this correlation strengthened with advances in gestational age. Most OCM-related metabolites measured in this study showed significant positive correlations between maternal blood at delivery and cord blood. These findings suggest that maternal OCM status may impact fetal development and indicate the need for comprehensive and longitudinal evaluations of OCM during pregnancy.
Assuntos
Sangue Fetal , Homocisteína , S-Adenosilmetionina , Humanos , Feminino , Sangue Fetal/metabolismo , Sangue Fetal/química , Gravidez , Adulto , Estudos Longitudinais , Homocisteína/sangue , Japão , S-Adenosilmetionina/sangue , S-Adenosil-Homocisteína/sangue , Estudos Transversais , Idade Gestacional , Carbono/metabolismo , Betaína/sangue , Cisteína/sangue , Espectrometria de Massas em Tandem , Glicina/sangue , População do Leste Asiático , Sarcosina/análogos & derivadosRESUMO
This work presents a significant investigation involving both electrochemical experiment and quantum chemical simulation approaches. The objective was to characterize the electrochemical detection of dopamine (DA). The detection was carried out using a modified carbon paste electrode (CPE) incorporating bentonite (Bent) and l-cysteine (CySH) (named as CySH/Bent/CPE). To understand and explain the oxidation mechanism of DA on the CySH/Bent modified electrode surface, the coupling of the two approaches were exploited. The CySH/Bent/CPE showed excellent electroactivity toward DA such as good sensibility, selectivity, stability, and regenerative ability. The developed sensor shows a dynamic linear range from 0.8 to 80 µM with a limit of detection and quantification of 0.5 µM and 1.5 µM, respectively. During the quantitative analysis of DA in presence of ascorbic acid (AA) and uric acid (UA) the electrochemical oxidation signals of AA, DA, and UA distinctly appear as three separate peaks. The potential differences between the peaks are 190 mv, 150 mv, and 340 mV for the AA-DA, DA-UA, and AA-UA oxidation pairs, respectively. These observations stem from square wave voltammetry (SWV) studies, along with the corresponding redox peak potential separations. The developed sensor is simple and accurate to monitor DA in human serum samples. On the other hand, CySH acts as an electrocatalyst on the CySH/Bent/CPE surface by increasing its active electron transfer sites, as suggested by the quantum chemical modeling with analytical results of Fukui. Furthermore, the voltammetric results obtained agree well with the theoretical calculations.
Assuntos
Bentonita , Carbono , Cisteína , Dopamina , Técnicas Eletroquímicas , Eletrodos , Dopamina/sangue , Dopamina/análise , Dopamina/química , Cisteína/química , Cisteína/análise , Cisteína/sangue , Carbono/química , Bentonita/química , Técnicas Eletroquímicas/métodos , Teoria Quântica , Oxirredução , Limite de Detecção , Humanos , Ácido Úrico/sangue , Ácido Úrico/química , Ácido Úrico/análiseRESUMO
L-cysteine, an indispensable amino acid present in natural proteins, plays pivotal roles in various biological processes. Consequently, precise and selective monitoring of its concentrations is imperative. Herein, we propose a Surface-enhanced Raman Scattering (SERS) sensor for detecting L-cysteine based on the anti-aggregation of 4-mercaptobenzoic acid (4-MBA) and histidine (His) functionalized silver nanoparticles (Ag NPs). The presence of Hg2+ ions can induce the aggregation of Ag NPs@His@4-MBA due to the unique nanostructures of Ag NPs@His@4-MBA, resulting in a robust SERS intensity of 4-MBA. However, in the presence of L-cysteine, the stronger affinity between L-cysteine and Hg2+ reduces the concentration of free Hg2+, causing the dispersion of the aggregated functionalized Ag NPs and the reduction of the SERS signal intensity of 4-MBA. The developed SERS platform demonstrates excellent performance with a low detection limit of 5 nM (S/N = 3) and linear detection capabilities within the range of 0.01-100 µM for L-cysteine. Additionally, the method was successfully employed for the determination of L-cysteine in spiked serum samples, yielding recoveries ranging from 95.0 % to 108.1 % with relative standard deviations of less than 3.3 %. This study not only presents a novel approach for fabricating highly sensitive and specific SERS biosensors for biomolecule detection but also offers a significant strategy for the development and construction of SERS substrates using anti-aggregation design.
Assuntos
Cisteína , Nanopartículas Metálicas , Prata , Análise Espectral Raman , Benzoatos/química , Cisteína/análise , Cisteína/sangue , Histidina/análise , Histidina/química , Histidina/sangue , Limite de Detecção , Nanopartículas Metálicas/química , Prata/química , Análise Espectral Raman/métodos , Compostos de Sulfidrila/química , Compostos de Sulfidrila/sangue , Compostos de Sulfidrila/análiseRESUMO
Biothiol assays offer vital insights into health assessment and facilitate the early detection of potential health issues, thereby enabling timely and effective interventions. In this study, we developed ultrasmall CuMn-Histidine (His) nanozymes with multiple enzymatic activities. CuMn-His enhanced peroxidase (POD)-like activity at neutral pH was achieved through hydrogen bonding and electrostatic effects. In addition, CuMn-His possesses laccase (LAC)-like and superoxide dismutase (SOD)-like activities at neutral pH. Based on three different enzyme mimetic activities of CuMn-His at neutral pH, the colorimetric sensing array without changing the buffer solution was successfully constructed. The array was successfully used for the identification of three biothiols, glutathione (GSH), cysteine (Cys), and homocysteine (Hcy). Subsequently, excellent application results were shown in complex serum and cellular level analyses. This study provides an innovative strategy for the development of ultrasmall bimetallic nanozymes with multiple enzymatic activities and the construction of colorimetric sensing arrays.
Assuntos
Colorimetria , Colorimetria/métodos , Concentração de Íons de Hidrogênio , Humanos , Histidina/química , Glutationa/sangue , Glutationa/química , Glutationa/análise , Homocisteína/sangue , Homocisteína/análise , Compostos de Sulfidrila/química , Nanoestruturas/química , Cisteína/sangue , Cisteína/análise , Cisteína/química , Superóxido Dismutase/química , Técnicas Biossensoriais/métodos , Lacase/química , Lacase/metabolismoRESUMO
This study aimed to examine the leukotriene metabolism during COVID-19. In total, 180 participants were included in this study, of which 60 were healthy controls, 60 required intensive care units (ICU), and 60 did not require intensive care (non-ICU). The serum levels of 5-lipoxygenase (5-LO), 5-LO activating protein (ALOX5AP), and cysteinyl leukotriene (CYSLT) were measured, and the mRNA expression levels of 5-LO, ALOX5AP, and cysteinyl leukotriene receptor 1 (CYSLTR1) were investigated. Compared with the control group, both the non-ICU and ICU groups had lower levels of 5-LO and mRNA expression. ICU patients had lower levels of 5-LO and mRNA expression than non-ICU patients. CYSLTR1 mRNA expression was highest in the ICU group, followed by the non-ICU group, and healthy controls had the lowest mRNA expression levels. CYSLT levels were higher in the control group than in the non-ICU and ICU groups. CYSLTR1 expression was higher in patients than in controls; therefore, selective leukotriene receptor blockers can be used as treatment options. CYSLTR1 expression was higher in the ICU group than in the non-ICU group. Furthermore, CYSLTR1 mRNA expression may be a promising biomarker of COVID-19 severity.
Assuntos
Araquidonato 5-Lipoxigenase , COVID-19 , Leucotrienos , Receptores de Leucotrienos , Humanos , COVID-19/metabolismo , Leucotrienos/metabolismo , Leucotrienos/sangue , Masculino , Pessoa de Meia-Idade , Feminino , Receptores de Leucotrienos/metabolismo , Receptores de Leucotrienos/genética , Araquidonato 5-Lipoxigenase/metabolismo , Araquidonato 5-Lipoxigenase/genética , Idoso , Proteínas Ativadoras de 5-Lipoxigenase/metabolismo , Proteínas Ativadoras de 5-Lipoxigenase/genética , Adulto , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , SARS-CoV-2 , Cisteína/sangue , Cisteína/metabolismo , Unidades de Terapia IntensivaRESUMO
Introduction: Studies have identified high serum homocysteine (Hcy) and cysteine (Cys) levels as risk factor for cardiovascular diseases, important cause of death in all world. The factors associated with high levels of these biochemistry markers in adults are well known; however, data are sparse on these associations in the pediatric age group. Objective: the objective was to identify factors associated with different concentrations of serum Hcy and Cys in children and adolescents. Methods: a cross-sectional study with 483 individuals of 7- 15 years of age of both sexes, from a municipality of Bahia. Serum Hcy and Cys levels were considered outcome variables, with exposure being evaluated according to sociodemographic, clinical, biochemical and lifestyle variables. Polytomous logistic regression was used to evaluate the association between exposure and outcome. Results: high serum Hcy levels were associated with being male (PR=3.74; p<0.01), age ≥12 years (PR=2.56; p<0.01), being overweight (PR=2.32; p=0.02), high blood pressure (PR=1.97; p<0.01), low HDL-c levels (PR=1.21; p=0.03), high triglyceride levels (PR=1.62; p=0.03) and poor intake of foods that protect against hyperhomocysteinemia (PR=1.46; p=0.02). High serum Cys levels were associated with age ≥12 years (PR=2.1; p=0.03), being overweight (PR=2.52; p=0.03); high blood pressure (PR=1.28; p=0.03), low HDL-c levels (PR=1.15; p=0.01), high triglyceride levels (PR=1.41; p=0.02) and poor intake of foods that protect against hypercysteinemia (PR=1.46; p=0.01). Conclusions: age >12 years, being overweight, high blood pressure, low HDL-c levels, high triglyceride levels and poor intake of protective foods are common factors found in individuals with increased serum Hcy and Cys levels. Being male was associated with high serum Hcy levels alone. Considering that these factors are already present early in life, measures should be adopted to prevent and control high Hcy and Cys levels, promoting health and preventing chronic non-communicable diseases at this stage of life
Introdução: Estudos têm identificado níveis séricos elevados de homocisteína (Hcy) e cisteína (Cys) como fatores de risco para doenças cardiovasculares, importante causa de morte em todo o mundo. Fatores associados com elevados níveis desse marcadores bioquímicos em adultos parecem bem conhecidos, no entanto na faixa etária pediátrica, dados sobre essas associações são escassos. Objetivo: identificar os fatores associados às diferentes concentrações séricas de homocisteína (hcy) e cisteína (cys) em crianças e adolescentes. Métodos: trata-se de um estudo transversal incluindo 483 indivíduos de 7 a 15 anos, ambos os sexos, de Mutuípe, Bahia. Níveis séricos de Hcy e Cys foram as variáveis desfecho, e condições sóciodemográficas, clínicas, bioquímicas e de estilo de vida foram incluídas como variáveis independentes. Utilizou-se a regressão logística politômica para avaliar a associação entre diferentes níveis de hcy e cys e variáveis de interesse, usando a razão de prevalência (RP) como medida de associação. Resultados: elevados níveis séricos de Hcy associaram-se ao sexo masculino (RP=3.74; p<0.01), idade ≥12 anos (RP=2.56; p<0.01), sobrepeso (RP=2.32; p=0.02), pressão arterial aumentada (RP=1.97; p<0.01), baixos níveis de HDL-c (RP=1.21; p=0.03), hipertrigliceridemia (RP=1.62; p=0.03) e baixo consumo de alimentos protetores (RP=1.46; p=0.02). Para a Cys, seus níveis aumentados associaram-se à idade ≥12 anos (RP=2.1; p=0.03), sobrepeso (RP=2.52; p=0.03); pressão arterial aumentada (PR=1.28; p=0.03), baixos níveis de HDL-c (RP=1.15; p=0.01), hipertrigliceridemia (RP=1.41; p=0.02) e baixo consumo de alimentos protetores (RP=1.46; p=0.01). Conclusões: idade ≥12 anos, sobrepeso, pressão arterial aumentada, baixos valores de HDL-c, hipertrigliceridemia e baixo consumo de alimentos protetores associaram-se aos níveis séricos elevados tanto de Hcy, quanto de Cys, com exceção do sexo masculino, que se associou apenas à hiperhomocisteinemia. Considerando que esses fatores têm apresentado ocorrência crescente na infância e adolescência, a prevenção e controle de níveis elevados de Hcy e Cys deve ser adotada, prevenindo doenças crônicas não transmissíveis nesse estágio da vida
No disponible
Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Homocisteína/sangue , Cisteína/sangue , Doenças Cardiovasculares/epidemiologia , Sobrepeso/epidemiologia , Fatores de Risco , Biomarcadores/análise , Estudos Transversais , Consumo de Álcool por Menores/estatística & dados numéricosRESUMO
RACIONAL: O câncer de esôfago tem impacto relevante no metabolismo protéico do hospedeiro, mas pouco se conhece sobre as implicações no metabolismo protéico sulfurado. Deste, destaca-se a taurina, composto participante de várias funções fisiológicas importantes como a manutenção do sistema de defesa celular e possível sobrevida do paciente. OBJETIVO: Estudar as variações plasmáticas da taurina e de seus precursores em pacientes com câncer de esôfago. MÉTODO: Em estudo transversal foram triados 16 pacientes (43-73 anos) com câncer de esôfago e 20 voluntários (27-65 anos) controles sadios que preencheram os critérios clínicos e éticos da pesquisa. Para caracterização do estado geral de saúde efetuou-se avaliação antropométrica, hematimétrica (Hb, Ht, glóbulos brancos, linfócitos) e bioquímica (albumina, glicose, lipídios, aminotransferases). Adicionalmente, foram realizadas, no plasma, análises cromatográficas de taurina e seus precursores cisteína e homocisteína. Foi registrado o tempo de sobrevivência dos pacientes, a partir do diagnóstico histopatológico. RESULTADOS: Os pacientes com câncer de esôfago foram predominantemente do sexo masculino, raça branca, classe socioeconômica baixa, tipo carcinoma espinocelular de localização no terço superior, em estádio IV, sobrevida de 7,8 ± 5,5 anos, referindo perda de peso em 16,4 por cento e apresentando hipoalbuminemia em 50 por cento, com massa muscular e adiposa semelhante ao controle. Os pacientes apresentaram valores estatisticamente menores do que os controles para Hb, Ht, colesterol total, HDL-colesterol e cisteína e maiores de AST, ALT, taurina e homocisteína. Dentre os pacientes houve correlação positiva da taurina tanto com a contagem total de linfócitos, como com a sobrevida dos pacientes. CONCLUSÃO: Os níveis reduzidos de cisteína e elevados de homocisteína, taurina e as associações positivas da taurina com os indicadores da imunocompetência celular e da mortalidade sugerem participação ...
BACKGROUND: The esophagus cancer-host has a two way close relationship as seen in its sulphur-amino acid metabolism. Taurine one of these compounds has ubiquous role in host defense and other physiological mechanisms related to survival. AIM: To study the plasma levels of taurine and its precursors in patients with esophagus cancer. METHODS: In a sectional design both groups, patients (n = 16, 43-73 yrs old) and healthy controls (n = 20, 27-65 yrs old) were assessed for anthropometry, body-weight lost, hematology (Hb, Ht, total leukocytes and lymphocyte counts), general biochemistry (albumin, glucose, lipids and aminotransferases) and chromatographic analysis for taurine, cysteine, and homocysteine. The survival time was registered there since from the clinical-histopathological diagnosis. All participants had a written ethical consent for the research. RESULTS: The cancer patients were predominantly, white males of low social economic class, with spinocellular carcinoma stage IV located at upper 3rd half of them presented hypoalbuminemia and 16 percent referred significant body-weight loss. The patients showed statistically lower values of Hb, Ht, total and HDL cholesterol and cysteine and significantly higher values of taurine, homocysteine and aminotransferases than healthy controls. A positive relationship was found between taurine and either TLC (r = 0.50) and survival (r = 0.81). CONCLUSIONS: Lower plasma cysteine along with higher levels of taurine and homocysteine and the positive direct association of taurine with indications of survival suggest an effective role of this compound and therefore a prospective special nutritional care in its precursors (cysteine, methionine and B vitamins) of these patients.
Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cisteína/sangue , Neoplasias Esofágicas/sangue , Homocisteína/sangue , Taurina/sangue , Estudos de Casos e Controles , Estudos Transversais , Estadiamento de Neoplasias , Análise de Sobrevida , Biomarcadores Tumorais/sangueRESUMO
N-acetyl-L-cysteine (NAC) has been proposed as an additional therapeutic agent for AIDS patients because it reduces human immunodeficiency virus type 1 (HIV-1) replication in stimulated CD4+ lymphocytes, and it ameliorates immunological reactivity. In a randomized, 180-day, double-blind, placebo-controlled trial performed with HIV-infected patients classified as A2 and A3 according to the criteria of the Center for Disease Control and Prevention, we investigated the effects of oral administration of NAC on HIV-infected patients undergoing their first anti-retroviral therapy; viral load, CD4+ lymphocyte, lymphocyte viability and apoptosis, and TNF-alpha and IL-8 levels were determined. Sixteen patients who received anti-retroviral therapy plus a placebo formed the control group and the study group consisted of 14 patients who received anti-retroviral therapy and NAC supplementation. A significant decrease was seen in viral load, TNF-alpha and IL-8 levels, and lymphocyte apoptosis, and a significant increase was found in levels of CD4+ lymphocytes and lymphocyte viability in both groups after anti-retroviral treatment, but no measurable benefits of anti-retroviral therapy plus NAC oral supplementation (600 mg/day) were found in relation to anti-retroviral therapy alone, and the baseline levels of cysteine and glutathione in plasma were not recovered by this treatment. In conclusion, the daily doses of NAC necessary for the total recuperation of plasma cysteine and glutathione levels in HIV-infected patients and the additional benefits following the supplementation of NAC in patients submitted to anti-retroviral therapy, need to be studied further.
Assuntos
Humanos , Adulto , Pessoa de Meia-Idade , Acetilcisteína/uso terapêutico , Fármacos Anti-HIV/uso terapêutico , Apoptose/efeitos dos fármacos , Infecções por HIV/tratamento farmacológico , /sangue , Linfócitos/efeitos dos fármacos , Fator de Necrose Tumoral alfa , Cisteína/sangue , Método Duplo-Cego , Glutationa/sangue , Infecções por HIV/sangue , Fatores de Tempo , Carga ViralRESUMO
A kininogen-like protein was purified from Bothrops jararaca plasma by DEAE-Sephadex ion-exchange and carboxy-methul-papain-Sepharose affinity chromatography. The molecular weight, estimated by SDS-gel electrophoresis, is about 100,000 and a species of about 75,000 is formed after incubation with hosrse urinary kallikrein. After incubation with rrypsin, only traces of biological activity were detected in tests on guinea pig ileum. The purified protein inhibits papain and bromelain, does not correct the clotting time of a kininogen-depleted human plasma, and does not affect the clotting time ogf plasma from Waglerophis merremii, a nonpoisonous snake; the same type of inhibitor was foind in this nonpoisonous snake. The dissociation cosntant (Ki) for the papain-inhibitor complex is approximately 1.6 nM
Assuntos
Animais , Humanos , Masculino , Feminino , Cininogênios/farmacologia , Cisteína/sangue , Coagulação Sanguínea , Elapidae/sangue , Cromatografia por Troca IônicaRESUMO
A glutationa, tripeptídeo constituída de glutomato, cisteína e glicinia, possui atividade química através do grupo SH. A glutationa apresenta-se normalmente na forma reduzida porém pode oxidar-se formando pontes dissulfeto entre duas moléculas. A síntese dA glutationa ocorre no interior da hemácia necessitando, para tanto, além dos aminoácidos constituintes da molécula,das enzimas y-glutamil cisteína sintetase e gglutationa sintetase. A glutationa reduzida, uma vez formada, näo tem capacidade de deixar o eritrócito. Existem pórem evidência de que A glutationa oxidada atravessa a membrana eritrocitária consumindo energia. Isto se faz necessário porque a gglutationa oxidada, entre outras atividades, tem a capacidade de inibir a enzima hexoquinase e reagir com a molécula de hemoglobina, alterando desta forma o funcionamento normal do eritrócito. A principal funçäo dA glutationa no interior do eritrócito é manter os grupos SH reativos na forma reduzida. Para que isso ocorra de forma adequada, é necessária a presença da enzimA glutationa redutase, catalisadora da reduçäo da glutationa oxidada. A glutationa redutase näo atua apenas nas pontes dissulfeto formadas pelA glutationa, mas também sobre outras ligaçöes dissulfeto formadas por proteínas eritrocitárias, tais como as da membrana celular. A hemoglobina é a principal constituinte do eritrócito e possui dois grupos SH reativos correspondentes à cisteína 93, constituintes das cadeias beta normais. Esses grupos säo preservados pelA glutationa redutase. Para que a açäo dA glutationa redutase seja adequada ela necessita de NADPH, gglutationa reduzida e flavina adenina dinucleotídeo (FAD). O NADPH é reduzido na via das pentoses pela açäo da glicose-6-fosfato desidrogenase (G6PD). O FAD é derivado fosforilado da riboflavina e atua como grupo prostético dA glutationa redutase...
Assuntos
Cisteína/sangue , Eritrócitos/metabolismo , Glutationa Redutase/sangue , Membrana Eritrocítica/metabolismo , Glutationa Redutase/induzido quimicamenteRESUMO
The 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) radical cation can be generated by incubation of ABTS and 2,2'-azo-bis(2-amidinopropane) at 45 degrees Celsius. The ABTS radical cation is stable for several minutes at room temperature and reacts quantitatively and instantaneously with several antioxidants, such as Trolox, ascorbic acid, uric acid, cysteine, glutathione and bilirubin. In contrast, the ABTS radical cation reacts slowly with albumin. When serum is added to a solution of the ABTS radical cation, the bleaching of the radical follows biphasic kinetics, with a fast decay followed by a slow decay that takes place within several minutes. The fast decay is primarily due to uric acid, while the slow decay is related to the protein content of the sample. We propose that this procedure can provide an independent and simultaneous evaluation of the low molecular weight and protein antioxidants present in biological samples such as serum.